Developing novel treatments for patients with atrial fibrillation

We are developing drugs designed to safety, effectively, and quickly get patients back to where they belong - in normal sinus rhythm.

About InCarda Therapeutics

Enabling restoration of a normal heart rhythm

We are focused on developing innovative products that can get patients back into normal sinus rhythm, whether in the hospital or at home.

Product pipeline

Our pipeline targets critical gaps in atrial fibrillation treatment across the continuum of care — from hospital to home.

We are eveloping a quick, safe and effective therapy to restore normal rhythm in paroxysmal AF and AFL.

We are developing self-administered therapy to convert atrial fibrilation — without leaving home.

A common irregular heartbeat that raises stroke risk but can be effectively treated